Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 262,000 shares, a decrease of 44.3% from the August 15th total of 470,600 shares. Based on an average daily volume of 953,800 shares, the short-interest ratio is presently 0.3 days.
Fresenius Medical Care AG & Co. KGaA Stock Down 0.7 %
NYSE:FMS traded down $0.12 on Friday, hitting $16.67. 1,785,818 shares of the company's stock were exchanged, compared to its average volume of 1,010,924. The firm has a 50-day moving average price of $19.14 and a 200-day moving average price of $26.32. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.18 and a quick ratio of 0.85. Fresenius Medical Care AG & Co. KGaA has a 52 week low of $16.06 and a 52 week high of $36.84. The company has a market cap of $9.77 billion, a P/E ratio of 10.62, a price-to-earnings-growth ratio of 0.84 and a beta of 1.03.
Get Fresenius Medical Care AG & Co. KGaA alerts:Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA
Institutional investors and hedge funds have recently modified their holdings of the company. FDx Advisors Inc. bought a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the 1st quarter valued at about $315,000. Freestone Capital Holdings LLC bought a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the 1st quarter valued at about $390,000. Guardian Capital Advisors LP raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 10.7% in the 1st quarter. Guardian Capital Advisors LP now owns 52,148 shares of the company's stock valued at $1,744,000 after purchasing an additional 5,045 shares during the period. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 18.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 4,706 shares of the company's stock valued at $158,000 after purchasing an additional 730 shares during the period. Finally, Cacti Asset Management LLC raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 35.8% in the 1st quarter. Cacti Asset Management LLC now owns 36,000 shares of the company's stock valued at $1,212,000 after purchasing an additional 9,500 shares during the period. 5.59% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
FMS has been the subject of a number of research analyst reports. StockNews.com initiated coverage on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Friday. They issued a "hold" rating for the company. Truist Financial reduced their target price on shares of Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a "hold" rating for the company in a research note on Wednesday, June 22nd. DZ Bank lowered shares of Fresenius Medical Care AG & Co. KGaA from a "buy" rating to a "hold" rating in a research note on Friday, July 29th. Berenberg Bank reduced their target price on shares of Fresenius Medical Care AG & Co. KGaA from €76.70 ($78.27) to €57.95 ($59.13) in a research note on Wednesday, August 10th. Finally, UBS Group lowered shares of Fresenius Medical Care AG & Co. KGaA from a "buy" rating to a "neutral" rating in a research note on Friday, July 29th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Fresenius Medical Care AG & Co. KGaA has a consensus rating of "Hold" and an average price target of $45.83.About Fresenius Medical Care AG & Co. KGaA
(Get Rating)
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
See Also
- Get a free copy of the StockNews.com research report on Fresenius Medical Care AG & Co. KGaA (FMS)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.